June 27, 2025
| Today’s news and insights for biopharma leaders
The agency removed some onerous requirements for the complex cancer drugs and reduced restrictions on patients’ post-treatment movement.
|
UPDATED
Thimerosal, targeted by activists who claim it’s linked to autism, shouldn't be used in vaccines given in the U.S. this coming flu season, the CDC panel said.
|
Many proposals to reform the PBM industry miss the forest for the trees, experts said this week. Instead, Congress should go after the oligopoly enjoyed by the “Big Three” companies.
|
Discover how GLP-1 drugs are reshaping weight loss and treatment horizons.
|
News roundup
Biocryst is offloading part of its business for $250 million. Meanwhile, the former FDA leader took issue with a new policy for COVID-19 shots.
|
The high court preserved a key part of the Affordable Care Act requiring private insurers cover a range of preventive healthcare services without cost sharing.
|
The biotech, which earlier this year laid off nearly all of its staff, also announced a PIPE that will hand it $175 million in new funding.
|
|
In today’s competitive pharmaceutical market, creative omnichannel campaigns help brands stand out amid complex regulations. Discover how to innovate strategies to drive growth in this playbook.
|
|
From Our Library
Playbook
Custom content for Medrio
|
Playbook
Custom content for WCG
|
| 
